跳至主要内容
临床试验/CTRI/2021/01/030363
CTRI/2021/01/030363已完成未知

Assessment of serological response to COVID-19 and its association with exposure to MR-containing vaccine: A pilot study

niversity College of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Group 1: COVID-19 positive children who have received MR-containing vaccine atleast 6 weeks before date of enrolment
  • Group 2: COVID 19 positive children who have not received MR containing vaccine

排除标准

  • Children with past infection due to measles or rubella, immunodeficiency states (both primary and secondary), chronic diseases (congenital heart disease, respiratory diseases that cause pulmonary function impairment, hypothyroidism, IDDM), history of blood transfusion within last 3 months, severe malnutrition (wt-for-ht <-3SD, MUAC <11.5cm, or bilateral pedal edema of nutritional origin), malignancy

研究者

发起方
niversity College of Medical Sciences

相似试验